Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$19,303
-$1,407 QoQ
Shares Held
2,069
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#444
of 639 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $1,827,271 across 5 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (1.1% of the industry book) .
All Filings in HLN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,303 | 2,069 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $20,710 | 2,069 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $20,917 | 2,069 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $29,917 | 2,885 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $29,686 | 2,885 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $27,522 | 2,885 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $30,523 | 2,885 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $23,830 | 2,885 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $24,493 | 2,885 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $90,587 | 11,007 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $73,287 | 8,798 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $73,727 | 8,798 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $71,615 | 8,798 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $70,384 | 8,798 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $53,579 | 8,798 | Shares | Sole | 2022-11-08 | |
| No filing history on record for this holder in this stock. | ||||||